Community lists
Seçki · Sağlık

Biotech

InspectStocks tarafındanPublished 14 Eki 202619 companies0 followers

Drug developers with approved medicines, built mainly on biologic and genetic science.

Bir yapay zekâ modelinin yardımıyla gruplandı ve editörlerimizce gözden geçirildi. Her şirketin altındaki satır, neden burada olduğunu söyler.

A
  • GILDGilead Sciences
    $169,73+%40,9 1Y

    Sells medicines for HIV, liver disease and cancer

  • BIIBBiogen
    $253,39+%56,9 1Y

    Develops and sells therapies for neurological diseases

  • NBIXNeurocrine Biosciences
    $174,35+%18,7 1Y

    Develops and sells therapies for neurological and endocrine disorders

  • EXELExelixis
    $70,71+%62,2 1Y

    Develops and sells cancer therapies

  • JAZZJazz Pharmaceuticals
    $248,18+%81,5 1Y

    Develops and sells neuroscience and oncology therapies

  • HALOHalozyme Therapeutics
    $101,69+%44,0 1Y

    Licenses drug delivery technology and sells enzyme-based therapies

  • KRYSKrystal Biotech
    $308,82+%52,1 1Y

    Develops and sells topical gene therapies for rare diseases

  • CORTCorcept Therapeutics
    $74,52-%4,9 1Y

    Develops and sells cortisol-modulating therapies

B
  • VRTXVertex Pharmaceuticals
    $547,02+%26,0 1Y

    Develops and sells cystic fibrosis and other medicines

  • ALNYBüyüme söndüğü için bir basamak aşağıAlnylam Pharmaceuticals
    $159,80-%64,7 1Y

    Develops and sells RNAi therapeutics

  • BBIOBridgeBio Pharma
    $79,53+%20,1 1Y

    Develops therapies for genetic diseases

  • BMRNBioMarin Pharmaceutical
    $58,32+%5,4 1Y

    Develops and sells therapies for rare genetic diseases

C
  • REGNRegeneron Pharmaceuticals
    $959,45+%41,5 1Y

    Develops and sells antibody therapies for eye, allergy and cancer conditions

  • MRNAModerna
    $248,70+%831,1 1Y

    Develops mRNA vaccines and therapies

  • INSMInsmed
    $120,64-%37,9 1Y

    Develops and sells therapies for rare lung diseases

  • UTHRBüyüme söndüğü için bir basamak aşağıUnited Therapeutics
    $595,58+%29,0 1Y

    Sells therapies for pulmonary arterial hypertension

  • INCYIncyte
    $122,23+%12,9 1Y

    Develops and sells oncology and inflammation therapies

D
  • ASNDAscendis Pharma A/S
    $259,10+%30,1 1Y

    Develops and sells endocrinology rare disease therapies

F
  • BNTXBioNTech
    $87,64-%21,5 1Y

    Develops mRNA vaccines and cancer therapies

DiscussionNo comments yet

Sign in to join the discussion

Be civil and stick to the companies. Comments are opinions, not advice.

    Lists are their owners' own, and notes and comments are opinions. Grades describe businesses from their filings; nothing here is a recommendation to buy or sell.